Primary Navigation for the CDC Website
CDC en EspaƱol


Division of Foodborne, Bacterial and Mycotic Diseases (DFBMD)

Histoplasmosis

General Information | Technical Information | Additional Information

Clinical Features

Symptomatic infection usually presents as a flu-like illness with fever, cough, headaches, and myalgias. Some patients fail to recover and develop chronic pulmonary infection or widespread disseminated infection (affecting mucosal surfaces, liver, spleen, adrenal gland and meninges). Acute septic presentation seen in some HIV-infected persons.

Etiologic Agent

Histoplasma capsulatum var. capsulatum. In Africa: H.capsulatum var. duboisii.

Resovoir

Soil contaminated with bird or bat droppings. Endemic in parts of the central and eastern United States along Ohio and Mississippi river valleys. Microfoci in Central and South America, Africa, India, and Southeast Asia.

Incidence

Approx. 80% of population living in areas with endemic disease is skin-test positive. Of HIV-infected persons in these areas, 10% - 25% develop disseminated histoplasmosis.

Back to Top

Sequelae

Permanent lung damage with chronic disease. Mortality rate is about 10% in HIV-infected persons with disseminated disease.

Transmission

Inhalation of airborne conidia (spores) after disturbance of contaminated soil.

Risk Groups

Persons in areas with endemic disease with exposures to accumulations of bird or bat droppings (e.g., construction or agricultural workers, spelunkers). High risk groups are immunocompromised persons (e.g., persons with cancer, transplant recipients, persons with HIV infection).

Back to Top

Surveillance

Reportable in some states in areas with endemic disease. No national surveillance exists.

Challenges

Identifying modifiable risk factors for disease in immunocompromised and debilitated persons. Developing sensitive and specific methods for earlier diagnosis. Determining which risk groups may benefit from chemoprophylaxis.

Opportunities

Defining risk factors for disease in immunocompromised persons. Developing more sensitive and specific tests for diagnosis.

Back to Top


Page last modified: March 27, 2008
Content Source: National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ZVED)

Program Contents

Contact Information

1600 Clifton Road NE
MS-C09
Atlanta, GA 30333
Phone: +1-800-311-1603